Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: New Zealand Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20132
20141
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Rutgers, The State University of New Jersey1
Takeda1
University of Sydney1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction7
Cardiovascular Diseases4
Acute Coronary Syndrome3
Stroke3
Hyperlipidemias2
ST Elevation Myocardial Infarction2
Anemia1
Angina, Unstable1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.